Investigational Drug Information for VNRX-7145
✉ Email this page to a colleague
What is the development status for investigational drug VNRX-7145?
VNRX-7145 is an investigational drug.
There have been 4 clinical trials for VNRX-7145.
The most recent clinical trial was a Phase 1 trial, which was initiated on June 8th 2021.
The most common disease condition in clinical trials is [disabled in preview]. The leading clinical trial sponsors are National Institute of Allergy and Infectious Diseases (NIAID), Venatorx Pharmaceuticals, Inc., and [disabled in preview].
There are six US patents protecting this investigational drug and fifteen international patents.
Summary for VNRX-7145
| US Patents | 6 |
| International Patents | 15 |
| US Patent Applications | 8 |
| WIPO Patent Applications | 7 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 1 (2021-06-08) |
| Vendors | 13 |
Recent Clinical Trials for VNRX-7145
| Title | Sponsor | Phase |
|---|---|---|
| Food Effect on Ceftibuten/VNRX-7145 in Healthy Participants | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 1 |
| Food Effect on Ceftibuten/VNRX-7145 in Healthy Participants | Venatorx Pharmaceuticals, Inc. | Phase 1 |
| Ceftibuten/VNRX-7145 in Participants With Varying Degrees of Renal Function | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 1 |
Clinical Trial Summary for VNRX-7145
Top disease conditions for VNRX-7145
Top clinical trial sponsors for VNRX-7145
US Patents for VNRX-7145
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| VNRX-7145 | ⤷ Start Trial | Beta-lactamase inhibitors | VenatoRx Pharmaceuticals Inc | ⤷ Start Trial |
| VNRX-7145 | ⤷ Start Trial | Combination compositions comprising a beta-lactamase inhibitor and uses thereof | VenatoRx Pharmaceuticals Inc | ⤷ Start Trial |
| VNRX-7145 | ⤷ Start Trial | Citrate coordination complex of an orally-delivered beta-lactamase inhibitor and uses thereof | VenatoRx Pharmaceuticals Inc | ⤷ Start Trial |
| VNRX-7145 | ⤷ Start Trial | Beta-lactamase inhibitors | VENATORX PHARMACEUTICALS, INC. (Malvern, PA) | ⤷ Start Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for VNRX-7145
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| VNRX-7145 | Australia | AU2015274530 | 2034-06-11 | ⤷ Start Trial |
| VNRX-7145 | Australia | AU2019264537 | 2034-06-11 | ⤷ Start Trial |
| VNRX-7145 | Canada | CA2950917 | 2034-06-11 | ⤷ Start Trial |
| VNRX-7145 | China | CN106687465 | 2034-06-11 | ⤷ Start Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
